Drug therapy management in patients with renal impairment: how to use creatinine-based formulas in clinical practice

Abstract

PurposeThe use of estimated glomerular filtration rate (eGFR) in daily clinical practice.MethodseGFR is a key component in drug therapy management (DTM) in patients with renal impairment. eGFR is routinely reported by laboratories whenever a serum creatinine testing is ordered. In this paper, we will discuss how to use eGFR knowing the limitations of serum creatinine-based formulas.ResultsBefore starting a renally excreted drug, an equally effective drug which can be used more safely in patients with renal impairment should be considered. If a renally excreted drug is needed, the reliability of the eGFR should be assessed and when needed, a 24-h urine creatinine clearance collection should be performed. After achieving the best approximation of the true GFR, we suggest a gradual drug dose adaptation according to the renal function. A different approach for drugs with a narrow therapeutic window (NTW) is recommended compared to drugs with a broad therapeutic window. For practical purposes, a therapeutic window of 5 or less was defined as a NTW and a list of NTW drugs is presented. Considerations about the drug dose may be different at the start of the therapy or during the therapy and depending on the indication. Monitoring effectiveness and adverse drug reactions are important, especially for NTW drugs. Dose adjustment should be based on an ongoing assessment of clinical status and risk versus the benefit of the used regimen.ConclusionWhen determining the most appropriate dosing regimen serum creatinine-based formulas should never be used naively but always in combination with clinical and pharmacological assessment of the individual patient.Electronic supplementary materialThe online version of this article (doi:10.1007/s00228-016-2113-2) contains supplementary material, which is available to authorized users.

Kidney function estimates using cystatin C versus creatinine: Impact on medication prescribing in acutely hospitalized elderly patients

“…Overall, the two major routes of drug elimination are kidney and liver. For drugs primarily excreted by the kidneys unchanged or as active metabolites, prescribing recommendations are influenced by kidney function . The rate of dosing discrepancies for CKD‐EPI Cr and CG Cr in our study population is high but consistent with existing literature regarding prescribing practices in the elderly .…”

A multifaceted intervention to reduce guideline non-adherence among prescribing physicians in Dutch hospitals

“…The guidelines were selected by a group of experts, including hospital pharmacists, clinical pharmacologists and hospital-based physicians in a consensus meeting. The selected guidelines had to relate to medication that has shown to frequently be involved in preventable, clinically relevant, drug-related problems [ 1 – 3 , 6 – 8 ]. All guidelines had to be part of a local implemented protocol in the hospital and were addressed in the educational program.…”

“…Many of these problems derive from prescribing errors that lead to potentially preventable morbidity, mortality and costs [ 5 ]. The majority of these are caused by pain medication, antithrombotics, antibacterial drugs, cardiovascular drugs, and drugs that are renally excreted [ 1 – 3 , 6 – 9 ].…”

Clinical Decision Support and Optional Point of Care Testing of Renal Function for Safe Use of Antibiotics in Elderly Patients: A Retrospective Study in Community Pharmacy Practice

“…Moreover, the eGFR can be an underestimation or overestimation of the actual value. Formulas for estimating GFR should be applied carefully, and the patients’ individual characteristics should be taken into account [ 32 , 33 ]. Future CDSSs could be improved by incorporating historical trends in patients’ renal function and patient characteristics affecting GFR estimates in the algorithms.…”